Florida Senate - 2025 SB 876
By Senator Berman
26-01316-25 2025876__
1 A bill to be entitled
2 An act relating to chimeric antigen receptor T-cell
3 therapy; creating ss. 627.64198, 627.6614, and
4 641.31078, F.S.; prohibiting health insurers and
5 health maintenance organizations issuing, delivering,
6 or renewing certain policies or contracts from
7 refusing to contract with or denying coverage for
8 certain providers of chimeric antigen receptor T-cell
9 therapy; providing an effective date.
10
11 Be It Enacted by the Legislature of the State of Florida:
12
13 Section 1. Section 627.64198, Florida Statutes, is created
14 to read:
15 627.64198 CAR-T therapy providers.—A health insurer
16 issuing, delivering, or renewing a health insurance policy in
17 this state on or after January 1, 2026, which provides coverage
18 for chimeric antigen receptor T-cell (CAR-T) therapy may not
19 refuse to contract with or deny coverage for the administration
20 of CAR-T therapy by any provider that qualifies as a certified
21 health care facility under the Food and Drug Administration
22 procedure for the CAR-T product license and that is included in
23 the policy’s provider network for any other service.
24 Section 2. Section 627.6614, Florida Statutes, is created
25 to read:
26 627.6614 CAR-T therapy providers.—A health insurer issuing,
27 delivering, or renewing a group health insurance policy in this
28 state on or after January 1, 2026, which provides coverage for
29 chimeric antigen receptor T-cell (CAR-T) therapy may not refuse
30 to contract with or deny coverage for the administration of CAR
31 T therapy by any provider that qualifies as a certified health
32 care facility under the Food and Drug Administration procedure
33 for the CAR-T product license and that is included in the
34 policy’s provider network for any other service.
35 Section 3. Section 641.31078, Florida Statutes, is created
36 to read:
37 641.31078 CAR-T therapy providers.—A health maintenance
38 organization issuing, delivering, or renewing a health
39 maintenance contract in this state on or after January 1, 2026,
40 which provides coverage for chimeric antigen receptor T-cell
41 (CAR-T) therapy may not refuse to contract with or deny coverage
42 for the administration of CAR-T therapy by any provider that
43 qualifies as a certified health care facility under the Food and
44 Drug Administration procedure for the CAR-T product license and
45 that is included in the policy’s provider network for any other
46 service.
47 Section 4. This act shall take effect January 1, 2026.